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Abstract  34 
The metabolic syndrome (MetS) is a major health issue worldwide and is associated with 35 
obesity, insulin resistance, and hypercholesterolemia. Several animal models were used to 36 
describe the MetS, however many of them do not mimic well the MetS pathophysiology in 37 
humans. The ApoE*3Leiden.CETP mouse model overcomes part of this limitation, since 38 
they have a humanised lipoprotein metabolism and a heterogeneous response to MetS, 39 
similarly to humans.  40 
The reported heterogeneity among them and their common classification into responder (R) 41 
and non-responder mice (NR); R mice show increased body weight, cholesterol and 42 
triglycerides levels, while NR mice do not show this expected phenotype when fed a 43 
Western type diet. To better define the differences between R and NR mice, we focused on 44 
feeding behavior, body weight gain, glucose tolerance, and lipid parameters, and on an 45 
extensive pathological examination along with liver histology analysis.  46 
Our data confirmed that R mice resemble the pathological features of the human MetS: 47 
obesity, dysplipidemia, glucose intolerance; NR mice do not develop the full dysmetabolic 48 
phenotype because of a severe inflammatory hepatic condition, which may heavily affect 49 
liver function.  50 
We conclude that R and NR mice are metabolically different and that NR mice have 51 
indications of severely impaired liver function. Hence, it is critical to identify and separate the 52 
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respective mice to decrease data heterogeneity. Clinical chemistry and histological analysis 53 
should be used to confirm retrospectively the animals’ classification. Moreover, we point out 54 
that NR mice may not be an appropriate control for studies involving ApoE*3Leiden.CETP R 55 
mice. 56 
 57 
New and Noteworthy 58 
Compared to some other animal models, ApoE*3Leiden.CETP mice are better models to 59 
describe the metabolic syndrome. However, there is phenotypic heterogeneity between 60 
"responder" and "non-responder" mice, the latter showing some evidence of hepatic 61 
pathology. A full phenotypic characterization and eventually post mortem analysis of the liver 62 
is warranted. 63 
  64 
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Introduction  65 
Obesity in humans (defined as Body Mass Index, BMI>30 kg/m2) is one of the major health 66 
problems worldwide and is expected to increase even more in the next decades (10). 67 
Although genetics factors are known to be involved in the pathogenesis of obesity (39, 64), 68 
its onset in the majority of people is due to excessive energy intake combined with a lack of 69 
physical activity. Obesity is often associated with other comorbidities such as cardiovascular 70 
diseases (CAD) (40), type 2 diabetes mellitus (T2DM) (57), hypertriglyceridemia (2), and 71 
non-alcoholic fatty liver disease (NAFLD) (3). Together these conditions form the metabolic 72 
syndrome (MetS) (24). Since obesity may induce insulin resistance or changes in lipoprotein 73 
metabolism, it may be considered the major driving force behind the MetS (12). While not all 74 
the underlying pathophysiological mechanisms are completely understood, the number of 75 
MetS patients increases (9). Thus, understanding and deciphering these mechanisms will 76 
hopefully provide new means to counteract the MetS epidemic.  77 
 78 
Several animal models, such as the diet-induced obese (DIO) mouse (58), the leptin-79 
receptor deficient db/db mouse (22) or the Zucker rat (65), have been used in the past 80 
decades to try to understand the consequences of a Western type diet on metabolism; 81 
however they typically do not develop all aspects of the MetS; in particular, the underlying 82 
genetic defects in the db/db mouse and the Zucker rat do not replicate the typical human 83 
pathophysiology. Moreover, there are animal models in which  features of the MetS (19) 84 
develop spontaneously on chow diet as for example in the DahlS.Z-Lepr+/Lepr+ rat (13), the 85 
Nile grass rat (33) or ZDSD rat (38). This does not occur in human patients, who rarely show 86 
sign of the MetS when fed a balanced low fat diet; usually, only when eating a Western type 87 
diet, the typical MetS symptoms develop. Taking this into account, in our studies, we used 88 
the double transgenic mouse model ApoE*3Leiden.human Cholesterol ester transfer protein 89 
(ApoE3L.CETP). The ApoE3Leiden mutation (14, 60) and the introduction of human CETP 90 
gene (60) make these mice' lipoprotein metabolism more similar to humans, thus making 91 
them one of the best animal models available to assess lipid metabolism in response to a 92 
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Western type diet (e.g. a 60% high fat supplemented with 0.25% cholesterol (HFHC) diet) 93 
(14, 60). Hence, these mice show a humanized lipoprotein metabolism, develop 94 
atherosclerosis when fed HFHC diet, and display a human-like response when treated with 95 
statins (51, 53). Compared to wildtype mice, they have higher concentrations of very low 96 
density lipoprotein (VLDL) and low density lipoprotein cholesterol (LDL-C), and relatively low 97 
concentrations of high density lipoprotein cholesterol (HDL-C) when fed the HFHC diet. The 98 
presence of the ApoE3Leiden transgene hampers the uptake of VLDL remnants by the liver 99 
leading to increased VLDL/LDL-C levels in plasma, similar to humans (60). Further, the 100 
introduction of the human glycoprotein CETP is responsible for the transport of cholesterol 101 
ester from HDL to apolipoprotein-B (apo-B) containing lipoproteins in exchange of 102 
triglycerides, leading to decreased HDL-C (60).  103 
The major aim of this study was to characterize the effect of long-term access to the HFHC 104 
diet in the ApoE3L.CETP mice on feeding behavior, and glucose and lipid metabolism. 105 
Interestingly, responses of ApoE3L.CETP mice to the HFHC diet are highly variable and 106 
therefore an attempt was made to clarify the causes of the observed heterogeneity inherent 107 
to this model. Our study highlighted in detail the presence of two different phenotypes within 108 
the same genetic background in ApoE3L.CETP mice: responder (R) mice and non-109 
responder (NR) mice. 110 
We characterized the morphological, metabolic and functional aspects of these two 111 
phenotypes through an extensive metabolic and histologic liver analysis of this mouse 112 
model. Our data indicate that only R ApoE3L.CETP mice recapitulate adequately the salient 113 
pathological features of human MetS. NR mice develop instead a prominent inflammatory 114 
hepatic condition that has detrimental effects on liver function, and may prevent the 115 
development of the expected “MetS phenotype”. Hence, the results of this study indicate that 116 
the high heterogeneity observed in this model might affect study outcomes, without an 117 
accurate distinction being made between R and NR animals.  118 
  119 
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Material and Methods 120 
Animals and husbandry 121 
Male ApoE3L.CETP mice (TNO, Innovation for Life, The Hague, Netherlands) (37, 60) aged 122 
7-19 weeks were used in all experiments. Prior to be delivered to our facility, 6-7 weeks old 123 
mice kept on a standard chow diet were tested by TNO for plasma total cholesterol and 124 
triglycerides levels; mice with triglycerides levels lower than 2 mmol/L (i.e. 177 mg/dL) were 125 
considered as NR mice, while those with triglycerides levels above this arbitrary threshold 126 
were classified as R mice. In the cohorts used in our experiments, particularly, NR mice had 127 
total cholesterol levels between 1.4 – 2.2 mmol/L (i.e. 54.1 - 84.9 mg/dL), and triglycerides 128 
between 0.6 - 1.9 mmol/L (i.e. 53.1 - 168.1 mg/dL), while R mice total cholesterol was higher 129 
than 1.9 mmol/L (i.e. 73.4 mg/dL) and triglycerides higher than 2.1 mmol/L (i.e. 185.8 mg/dL) 130 
at 6-7 weeks of age. For consistency, we will report henceforth our study data only in mg/dL 131 
units, and refer to both mmol/L and mg/dL only for data collected at TNO. 132 
Two different cohorts of R mice and NR mice were ordered from TNO. Upon arrival at our 133 
facility, R ApoE3L.CETP mice and NR ApoE3L.CETP mice separated based on TNO 134 
plasma results, were group housed as they were shipped (2-5 mice per cage). Mice were 135 
housed at a temperature of 21°C with an artificial 12h light-dark cycle (light on 2:00 am, light 136 
off 2:00 pm). Individual mice had to be isolated due to fighting reasons, whilst a group of 137 
mice (cohort 2, group 3 in Table 1) was single-housed for indirect telemetry experiment. R 138 
mice and NR mice used in the different experiments were in the same range of age. 139 
They were acclimated to the new housing and environmental conditions for 2 weeks prior to 140 
the start of the experiments. During the acclimation period and for the following 2 weeks, 141 
mice were fed a chow diet (22.4% protein, 12.3% fat and 65.4% carbohydrate, #3436, Kliba 142 
Nafag, Kaiseraugst, Switzerland) after which they were switched to a high fat high 143 
cholesterol diet containing 60% kcal fat and 0.25% cholesterol (D14010701, HFHC diet, 144 
Research Diets, New Brunswick NJ, USA) until the end of the experiments. This was a 145 
custom diet modified from the original 60% kcal diet containing 25% protein, 36% fat and 146 
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25% carbohydrate. More detail on the experimental design is given in Table 1. The Cantonal 147 
Veterinary Office of Zurich approved all the animal experiments (licence 122/2014).  148 
 149 
Animal health 150 
Mice imported from TNO were negative for endo- and ectoparasites, viruses and bacteria, 151 
as indicated by the latest FELASA-compliant health reports (results not shown). Sentinel 152 
mice at our facility were tested quarterly and resulted negative for major etiologic agents. 153 
Additional testing was conducted to confirm the specific pathogen free health status for 154 
Helicobacter spp. using qPCR on pooled frozen liver samples obtained from R mice and NR 155 
mice used in this study (n=3). The qPCR analysis was conducted in a diagnostic laboratory 156 
(Idexx Bioresearch, Ludwigsburg, Germany) using Helicobacter genus and Helicobacter 157 
species-specific PCR primers.  158 
 159 
Body weight and body composition  160 
Body weight was measured weekly from arrival at the facility until the end of the 161 
experiments. After sacrifice, 7 mice from each group were subjected to CT scanning 162 
(LaTheta LCT-100A scanner, Hitachi-Aloka Medical Ltd., Tokyo, Japan) for body 163 
composition, and the proportion between lean and fat mass (subcutaneous and intra-164 
abdominal adipose tissue) in the region between lumbar vertebrae L1-L5 was analyzed 165 
using LaTheta software (version 2.10, Hitachi-Aloka Medical Ltd.) (15, 56).  166 
 167 
Feeding behavior 168 
Individual food consumption was investigated for an entire week in single-housed mice. 24-169 
hour cumulative food intake was manually assessed then a proper feeding behavior study 170 
was performed.  171 
After 6 weeks of HFHC diet feeding, R mice (n=8) and NR mice (n=8) were single-housed in 172 
BIODAQ cages (Research Diets, New Brunswick, NJ, USA) equipped with external food 173 
hoppers to measure food intake continuously. Meal size and meal pattern over 24h were 174 
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then determined. Meal pattern data collected from each mouse were grouped into meals by 175 
clustering independent feeding bouts. A meal was defined as a minimum inter-meal interval 176 
(IMI) of 600 sec and minimum size of 0.02 g (48). Mice were not disturbed during these 177 
measurements.  178 
The same mice were then transferred to an open-circuit indirect calorimetric system (TSE 179 
Phenomaster, TSE Systems GmbH, Bad Homburg, Germany) to monitor metabolic rate and 180 
respiratory gas exchange. Two weeks of adaptation were given prior to measurements for 181 
each test.  182 
 183 
Glucose metabolism: oral glucose tolerance test and insulin sensitivity test  184 
Oral glucose tolerance (OGTT) and insulin sensitivity (IST) tests were carried out in separate 185 
groups of R mice and NR mice to avoid stress and excessive blood sampling. 186 
OGTTs were performed in R mice and NR mice on chow diet and after 1, 2 and 3 months of 187 
HFHC diet feeding (n=28 each time-point per group). Mice were fasted for 6h prior to the test 188 
and were briefly anesthetized with isoflurane (3% isoflurane in the induction chamber, 189 
0.8L/min) to collect blood in microvette EDTA microtubes (Sarstedt, Nümbrecht, Germany) 190 
by sublingual vein puncture to measure basal glucose and insulin levels. At T0, a baseline 191 
blood sample was collected and a bolus of glucose (2g/kg) was given by oral gavage, after 192 
which blood was sampled by tongue bleeding at time 15 and 30 min, and by tail bleeding at 193 
time 45, 60, 90 and 120 min for glucose measurements (Breeze 2, Bayer Glucose Meter, 194 
Basel, Switzerland). The area under the curve (AUC) was calculated above the lowest 195 
glucose value of each mouse during the OGTT. Blood was kept on ice and centrifuged at 196 
4°C for 5 min at 11000 rpm. EDTA plasma was separated and stored at -80°C until assayed. 197 
Insulin levels at time-points 0, 15 and 30 min were measured with a specific Mouse Insulin 198 
ELISA (Mercodia AB, Uppsala, Sweden) (Data not shown).  199 
ISTs were performed using different cohorts of R mice (n=19) and NR mice (n=15), which 200 
were fasted for 4h and bled at the same time-points (see above). After baseline blood 201 
sample measurements, insulin Humalog (0.5U/kg, 100U.I./mL, Lilly, Geneva, Switzerland) 202 
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was injected intraperitoneally and blood glucose levels were measured at 15, 30, 45, 60, 90 203 
and 120 min after injection in blood samples collected by tail bleeding. Mice that became 204 
hypoglycemic (i.e. reached glucose levels of 2.5 mmol/L or less) were immediately given a 205 
bolus of glucose (2g/kg) and were excluded from the test for all subsequent time-points. In 206 
our analysis particularly, 9/27 R mice and 8/23 NR mice were excluded. The AUC was 207 
calculated above the lowest level of glucose of each mouse during IST test. 208 
 209 
Cytokines and transaminase measurements 210 
Cytokines were measured in plasma isolated from terminal blood samples with V-Plex 211 
Cytokine kit (Meso Scale Discovery, Gaithersburg, MD, USA) following the manufacturer’s 212 
protocol.  213 
Plasma alanine transaminase (ALT) was measured via UniCel® DxC 800 Synchron® 214 
Clinical System in plasma of R mice and NR mice at the time of sacrifice, according to 215 
manufacturer’s instructions. 216 
 217 
Liver and pancreas histology  218 
All animals were deeply anesthetized by isoflurane and sacrificed via opening of the thoracic 219 
cavity and exsanguination by cardiac puncture. A complete necropsy, including a thorough 220 
external and internal gross examination, was performed on each mouse. Mice were 221 
sacrificed at different time-points after 2, 3 and 4 months of HFHC diet feeding. Organs of 222 
interest (liver, kidneys, heart, pancreas, epididymal white adipose tissue (WAT), periaortic 223 
brown adipose tissue (PBAT), and aorta) were removed, weighed (liver) and appropriately 224 
sized samples were fixed in 10% neutral-buffered formalin (Formafix, Hittnau, Switzerland) 225 
or snap frozen. After fixation, all collected organs and tissues were trimmed according to 226 
guidelines (43), dehydrated through graded alcohols and routinely paraffin wax embedded. 227 
Consecutive sections (3–5 µm) were prepared, mounted on glass slides and routinely 228 
stained with hematoxylin eosin (HE) or subjected to immunohistochemical staining. 229 
Microscopic findings in the HE-stained slides were classified with standard pathological 230 
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nomenclature and severities of findings were graded on a scale of 0 to 4 (no finding present 231 
(0), minimal (1), mild (2), moderate (3), or severe (4)). Grades of severity for microscopic 232 
findings were subjective; minimal was the least extent discernible and severe was the 233 
greatest extent possible (47). Lesions that were not graded were marked as present. 234 
Nomenclature of the microscopic observations in the liver was consistent with INHAND 235 
published guides (50). A silver stain was performed on the formalin-fixed paraffin-embedded 236 
liver sections of selected mice according to routine procedures to exclude the presence of 237 
argyrophilic bacteria. 238 
Immunohistochemistry for the CD45 (Clone I3/2.3, Abcam ab25386, dilution 1:2000) was 239 
employed on the liver and kidneys sections of selected mice (R mice=8, NR mice=8) for the 240 
quantitative assessment of the inflammatory infiltrate. Slides were scanned in bright field at 241 
×40 magnification using a digital slide scanner (NanoZoomer-XR C12000, Hamamatsu 242 
Photonics K.K., Japan) and the positive reaction was quantified on forty 500 µm2-sized 243 
regions of interest randomly selected throughout the parenchyma using the Visiopharm 244 
Integrator System (VIS, version 4.5.1.324, Visiopharm, Hørsholm, Denmark). Briefly, a 245 
classification based on a threshold of pixel values allowed recognition of the positive (brown) 246 
CD45 signal and the results were expressed as area of positive-stained cells(µm2)/mm2 of 247 
tissue. In addition, antibodies against CD3 (Clone SP7, Bioscience M3074, dilution 1:900), 248 
CD45R/B220 (clone RA3-682, BD Pharmigen, dilution 1:800) and F4/80 (clone SP115, 249 
Invitrogen MA5-16363 dilution 1:150) were used for the characterization of T cells, B cells 250 
and macrophages, respectively. A pan cytokeratin antibody (clone PCK-26, Novus 251 
Biological, dilution 1:500) was used for the identification of biliary duct epithelial cells.  252 
Oil red O (ORO) staining was performed on snap-frozen cryomold-embedded livers. 253 
Sections were cut at 6 μm, mounted on glass slides and allowed to dry at room temperature. 254 
They were then rinsed briefly in 50% ethanol, incubated in a 60% aqueous ORO solution 255 
(375.0 mg Oil Red O (Merck KGaA, Darmstadt, Germany) in isopropanol) at room 256 
temperature for 20 min, rinsed again in 50% ethanol and counterstained with hematoxylin for 257 
2 min. ORO stained slides were scanned and then analyzed as previously described. For 258 
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quantification, a threshold classification was set up to allow recognition of positive (red) 259 
hepatocellular cytoplasm and negative hepatic parenchyma. The results were expressed as 260 
positive area versus total area in the whole liver section. Data are presented as average (± 261 
SEM) percentage of lipid-containing parenchyma in the group. 262 
 263 
Triglycerides and non-esterified fatty acids in livers 264 
Approx. 50 mg of snap frozen liver were homogenized with 1 mL 2:1 chloroform:methanol 265 
(v/v) solution to measure triglyceride content. The homogenate was centrifuged for 5 min at 266 
2500 rpm and supernatant was collected and diluted with 0.9% NaCl. Samples were 267 
centrifuged for 5 min 2000 rpm, then resuspended in a 1:1 methanol:H2O (v/v) solution. The 268 
upper phase was then discarded, samples were let to dry and resuspended in Dimethyl 269 
sulfoxide (DMSO). Triglycerides content was then measured with the Cobas Mira Roche-270 
Autoanalyzer (F. Hoffmann-La Roche Ltd., Basel, Switzerland), according to the 271 
manufacturer’s instructions. Non-esterified fatty acids (NEFA) were measured on approx. 10 272 
mg frozen liver following manufacturers’ procedure (Merck KGaA, Darmstadt, Germany).  273 
 274 
Pancreatic islets isolation and glucose-stimulated insulin secretion  275 
At time of sacrifice, whole pancreas was digested and pancreatic islets were isolated using 276 
the adapted islets isolation procedure from Nordmann et al (34) from all cohort of mice, 277 
except for mice (R mice=8, NR mice=8) in cohort 2, group 3 (Table 1). Subsequently, 278 
isolated islets were let recover for 2h in a cell culture incubator (37°C, 20%O2 and 5%CO2) 279 
and 10 islets/well were gently picked and plated into a 24 well ECM plate (Novamed, 280 
Jerusalem, Israel). Media was changed on day 2 and on day 4 when the glucose-stimulated 281 
insulin secretion (GSIS) test was performed following a procedure adapted from Rütti (44). 282 
Krebs-Ringer phosphate solution supplemented with 0.1% BSA and 1M Hepes was 283 
prepared (KRH). Islets were pre-incubated for 30 min in KRH supplemented with 2.8 mM 284 
glucose at 37°C to let islets adapt to KRH solution before collection of the supernatant to 285 
measure insulin secretion. To measure basal insulin release, islets were incubated for 1h 286 
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with fresh KRH + 2.8 mM glucose followed by 1h with KRH + 13.7 mM glucose to measure 287 
stimulated insulin release. After each incubation, supernatant was collected, immediately 288 
frozen and later used to measure secreted insulin. To quantify insulin content after the two 289 
incubations, islets were lysed with 0.18M HCl in 70% EtOH at 4°C overnight. Insulin was 290 
measured with the Mouse Insulin ELISA (Mercodia AB, Uppsala, Sweden) and secreted 291 
insulin was calculated as percentage of total insulin content.  292 
 293 
Lipid parameters 294 
Plasma total cholesterol and triglycerides were measured at TNO when mice were 6-7 295 
weeks old to discriminate between R mice and NR mice. For consistency, we converted the 296 
unit for total cholesterol and triglyceride received from the TNO facility from mmol/L to mg/dL 297 
because all the measurements performed in our institute used this unit system. For our own 298 
measurements, an aliquot of blood collected from mice undergoing the IST was collected in 299 
Microvette Lithium-heparin vacutainers (Sarstedt, Nümbrecht, Germany) and used to 300 
analyze lipid parameters. An additional blood sample was collected at sacrifice by cardiac 301 
puncture. Blood was immediately centrifuged at 11000 rpm at 4°C for 5 min and heparin 302 
plasma was aliquoted and stored at -80°C until assayed. Triglycerides, HDL-C and total 303 
cholesterol levels were analysed via UniCel® DxC 800 Synchron® Clinical System 304 
according to manufacturer’s instructions, measured in mg/dL. Non-esterified fatty acids (HR 305 
Series NEFA –HR, Wako, Virginia, USA) and beta-hydroxybutyrate (Randox D-3-306 
Hydroxybutyrate, Randoy Laboratories Ltd., Crumlin, County Antrim, United Kingdom) were 307 
analysed in blood samples collected at sacrifice using a Cobas Mira Roche-Autoanalyzer (F. 308 
Hoffmann-La Roche Ltd., Basel, Switzerland), according to the manufacturer’s instructions. 309 
CETP activity was measured in plasma collected at sacrifice with CETP activity assay 310 
(CETP activity assay kit, MAK106, Merck KGaA, Darmstadt, Germany) according to 311 
manufacturer’s instructions.   312 
 313 
 314 
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Bile acids profile in plasma and feces 315 
Samples were analyzed by the Department of Laboratory Medicine, University of Groningen, 316 
using 25 µL of plasma and 50 mg of feces. For plasma samples, to each sample, 250 µL 317 
internal standard solution (0.1 µM D4-CA and DA-CDCA, 0.2 µM DA-TCA, DA-TCDCA, DA-318 
GCA, D6-TDCA, D4-TUDCA, D4-T-MCA and D4-GCDCA) was added and vortexed. 319 
Samples were then centrifuged at 11000 rpm and the supernatant transferred into a clean 320 
glass tube. The liquid phase was then evaporated under nitrogen at 40°C. Before 321 
measuring, samples were reconstituted in 200 µL 1:1 methanol:H2O (v/v), vortexed for 60 322 
sec and centrifuged for 3 min at 4000 rpm. The supernatant was transferred into a 0.2 µm 323 
spin-filter and centrifuged at 4200 rpm for 10 min. After filtering, the samples were analyzed 324 
(10 µL injection volume) by Nexera X2 Ultra High Performance Liquid Chromatography 325 
system (SHIMADZU, Kyoto, Japan), coupled to a SCIEX QTRAP 4500 MD triple quadrupole 326 
mass spectrometer (SCIEX, Framingham, MA, USA) (UHPLC-MS/MS) (37). 327 
For feces samples, bile acid composition was determined by capillary gas chromatography 328 
on a Hewlett-Packard gas chromatograph (HP 6890) equipped with a FID and a CP Sil 19 329 
capillary column; length 25 m, internal diameter 250 µm and a film thickness of 0.2 µm 330 
(Chrompack BV, Middelburg, The Netherlands). Bile acids were methylated with a mixture of 331 
methanol and acetyl chloride and trimethylsilylated with a mixture of piridyne, N,O-Bis 332 
(trimethylsilyl) trifluoroacetamide and trimethylchlorosilane. Neutral sterols were 333 
trimethylsilylated with a mixture of piridyne, N,O-Bis (trimethylsilyl) trifluoroacetamide and 334 
trimethylchlorosilane and measured on the same gas chromatograph equipped with the 335 
same column. 336 
 337 
Data Analysis and Statistics 338 
All data are expressed as mean  standard error of the mean. Student’s T-test, 2 way-339 
ANOVA followed by Tukey or Sidak post-hoc tests were used for comparison among the 340 
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groups (NR mice vs R mice), as appropriate. For all statistical analysis, a p-value lower than 341 
0.05 was considered significant. Data were analyzed using Prism GraphPad 8.0.   342 
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RESULTS  343 
Body weight, food intake, indirect calorimetry and body composition in R and NR 344 
mice 345 
Upon arrival in our facility on chow diet, R mice and NR mice did not show any differences in 346 
body weight. R mice gained significantly more body weight (initial body weight 31.2  0.6 g 347 
and final body weight 49.7  1.1 g) compared to NR mice (initial body weight 29.0   0.4 g 348 
and final body weight 39.0  0.9 g) after 16 weeks of HFHC diet feeding (Fig 1A). The 349 
difference in body weight was significant from the 2nd week of HFHC diet feeding. 350 
Body composition analysis showed no significant difference in lean mass (Fig 1F) and total 351 
fat mass between R mice and NR mice; nevertheless, NR mice had a tendency for 352 
decreased subcutaneous and significantly less intra-abdominal fat compared to R mice (Fig 353 
1G). 354 
Ad libitum food intake over 24h (Fig 1B), number of meals per day (Fig 1C) and parameters 355 
of energy metabolism (respiratory exchange ratio (Fig 1D) and energy expenditure (Fig 1E) 356 
revealed no difference between the two groups. 357 
 358 
Glucose and insulin tolerance in R mice and NR mice 359 
Oral glucose tolerance tests (OGTT) were performed at several time-points in mice on chow 360 
diet and after 1, 2 and 3 months of HFHC feeding diet, respectively (Fig 2A-D). Already 361 
when chow fed, R mice and NR mice displayed differences in their glucose metabolism (Fig 362 
2A). Fasting (baseline) glucose levels were higher in R mice (10.4  0.3 mmol/L) compared 363 
to NR mice (8.5  0.3 mmol/L) and, with the exception of the 15 min time-point, this trend 364 
continued during the entire OGTT (Fig 2A). Although this difference at specific time-points, 365 
both groups were able to reach baseline values after 120 min of test, indicating similar 366 
glucose tolerance; even though AUC on chow diet of R mice was increased by 20% as 367 
compared to NR mice (Fig 2I), the difference did not reach significance.  368 
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The difference between R mice and NR mice became more pronounced when mice were 369 
HFHC diet fed. Notably, after 1 month of HFHC diet feeding, R mice became glucose 370 
intolerant with higher glucose levels as compared to NR mice during the entire OGTT (Fig 371 
2B). This effect was exacerbated after 2 and 3 months of HFHC diet feeding (Fig 2C-D). 372 
After 3 months of HFHC diet, NR mice also slightly increased their glucose levels probably 373 
due to aging and the consequences of HFHC diet feeding (35). This was also reflected in the 374 
higher AUC (Fig 2I) compared to earlier time-points. 375 
Insulin sensitivity tests (IST) were performed in different groups of mice at the same time-376 
point as the OGTT (Fig 2E-H). R mice, as previously observed during the OGTT, displayed 377 
higher glucose level at times 0 and 15 compared to NR mice. Already on chow diet (Fig 2E), 378 
and after 1 month of HFHC diet feeding (Fig 2F), NR mice showed a better insulin sensitivity 379 
response compared to R mice (indicated by the higher AUC in NR mice; Fig 2J). Over time, 380 
the differences between the two groups decreased probably due to aging effect (Fig 2G-H), 381 
without reaching significance in the AUC (Fig 2J). Thus, even though R mice display higher 382 
glucose values during the IST, which indicates reduced glucose tolerance, on HFHC diet, 383 
based on the AUC during the IST, their overall insulin sensitivity was similar to NR mice (Fig 384 
2J). 385 
 386 
Histopathology of selected organs morphology and lipid profile in the liver of R mice 387 
and NR mice 388 
The post mortem evaluation revealed clear differences in the liver of R and NR mice. There 389 
was no gross abnormality detected in livers of R mice euthanized at approximately 14-16 390 
weeks of age and kept on the chow diet, whilst livers of NR mice under the same 391 
experimental conditions appeared firmer than normal and exhibited a rough granular surface 392 
with multiple ill-demarcated indentations (not shown). Livers of 20-34 weeks old R mice fed 393 
the HFHC diet for 2, 3 or 4 months, respectively, were mildly enlarged, with rounded 394 
borders, and exhibited a diffuse yellow-brown discoloration and a homogeneously smooth 395 
surface (Fig 3A). Age-matched NR mice receiving the HFHC diet presented small, firm 396 
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livers, with an extremely irregular granular surface, along with rare (3/30 NR mice) multifocal 397 
nodular masses, 0.1-0.4 cm in diameter (Fig 3B). 398 
In line with these macroscopic observations, there was a statistically significant decrease in 399 
mean absolute liver weights in 20-34 weeks old, HFHC diet fed NR mice when compared to 400 
R mice under the same experimental conditions (1.8  0.2 vs 2.9  0.3 g; p < 0.01) (Fig 3I). 401 
The results of the histopathological analysis are presented in Table 2. Apart from the 402 
presence of variably sized, predominantly periportal cytoplasmic eosinophilic inclusions (up 403 
to 20 µm in diameter) within the hepatocytes, indicative of mutant Apo-E lipoprotein 404 
accumulation (30), no histological abnormality was observed in the liver of R mice (5/5) fed 405 
the chow diet (Fig 3C). In contrast, NR mice (5/5) exhibited a minimal inflammatory 406 
response, alongside a slightly increased severity of eosinophilic droplets (average severity 407 
3.3  0.3 in R mice vs 4.0  0 in NR mice). Inflammation was characterized by scattered, 408 
predominantly periportal foci of lymphocytes, macrophages and neutrophils, associated with 409 
minimal bile duct proliferation (Fig 3D, Table 2). 410 
After HFHC diet feeding, mice from both groups exhibited minimal to severe macro- and 411 
micro-vesicular hepatic lipidosis (Fig 3E-F, Table 2), which progressively increased in 412 
severity with time (Table 3). Lipidosis was mainly microvesicular in R mice and occurred with 413 
a higher average severity (3.3  0.2) compared to NR mice (1.8  0.2), in which a 414 
macrovacuolar pattern was noted more often. Histomorphometrical analysis of lipid droplets 415 
in liver sections stained with the ORO method confirmed this result, with livers of R mice 416 
showing higher proportions of fat content vs total parenchyma (76.6%) compared to NR 417 
mice livers (53.1%) (Fig 3E-F inset). The higher grade of hepatic lipidosis correlated with 418 
increased triglycerides levels (1.5  0.1 mg/dL/g vs 2.7  0.1 mg/dL/g) and non-esterified 419 
fatty acids (45.5  3.6 mmol/L/g vs 49.9  5.1 mmol/L/g) in livers of R mice vs NR mice (Fig 420 
3G-H). 421 
Chronic inflammation was also observed in both groups and occurred with higher incidence 422 
and severity in NR mice compared to R mice (Fig 4A-L, Table 2), as confirmed by the 423 
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quantitative assessment of the CD45 positive reaction (NR mice liver=2121  504.5 CD45+ 424 
signal/mm2 of tissue compared to R mice=889.1  111.9 CD45+ signal/mm2 of tissue) (Fig 425 
4K-L). In the latter, the inflammatory reaction consisted of scattered aggregates of 426 
lymphocytes and macrophages, clustering within or at the periphery of lipidotic areas, 427 
associated with minimal bile duct proliferation (Fig 4A and 4C-F).  428 
 The liver of NR mice showed, instead, a prominent mixed chronic inflammatory cell 429 
infiltration expanding and bridging portal areas, dominated by T and B cells and 430 
macrophages, along with fewer plasma cell and neutrophils (Fig 4B and 4G-J). Chronic 431 
inflammation was accompanied by minimal fibrosis and prominent bile duct hyperplasia (Fig 432 
4B and 4G-J).  433 
A few (3/30) NR mice exhibited proliferative preneoplastic or neoplastic lesions, such as 434 
eosinophilic and clear cell foci of hepatocellular alteration (1/30, Fig 4M) and hepatocellular 435 
adenomas (2/30, Fig 4N), which correlated with the nodular masses observed 436 
macroscopically. There was no evidence of hepatocellular proliferative lesions in R mice. 437 
Cytoplasmic eosinophilic inclusions occurred with lower severity in mice fed with the HFHC 438 
diet, compared to mice given a chow diet. This might be due to aging or to the concurrent 439 
high degree of lipidosis, which somehow prevents the formation or detection of these 440 
structures. However, similarly to mice fed with the chow diet, eosinophilic inclusions were 441 
observed with increased severity in NR mice (2.0  0.3) compared to R mice (0.8  0.2). 442 
No histological abnormality was detected in the remaining examined organs, such as PBAT 443 
and aorta, kidney, epididymal WAT, and heart (Fig 4 O-V). In particular, there was no 444 
evidence of inflammatory changes. Histomorphometry conducted on renal sections 445 
immunostained for CD45 revealed no significant difference between R mice (8610  2175 446 
CD45+/mm2) and NR mice (8764  2442 CD45+/mm2) (Fig 4Y). 447 
Thus, we observed two distinct hepatic pathophenotypes under HFHC diet feeding 448 
conditions. R mice showed increased lipidosis (mainly microlipidosis) along with mild 449 
inflammation, while NR mice showed lower lipidosis levels (mainly macrolipidosis) but higher 450 
Downloaded from www.physiology.org/journal/ajpgi by ${individualUser.givenNames} ${individualUser.surname} (130.060.098.172) on August 9, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
 19 
incidence and severity of chronic inflammation; along with evidence of hepatocellular 451 
proliferative lesions in a small proportion of cases.  452 
 453 
Pancreas  454 
In line with the lack of meaningful histological abnormality in the exocrine and endocrine 455 
pancreas (data not shown), static glucose stimulation in isolated islets from R mice and NR 456 
mice induced a similar increase in insulin secretion in pancreatic islets isolated from R mice 457 
and NR mice (Fig 6I).  458 
 459 
Cytokines and Transaminase in circulating blood of R mice and NR mice 460 
Plasma cytokines concentrations were similar between R mice and NR mice at time of 461 
sacrifice, i.e. after 3 months of HFHC feeding (Fig 5).  462 
However, increased levels of alanine transaminase (ALT) were observed in NR mice after 3 463 
months of HFHC diet compared to chow conditions and compared to R mice at the same 464 
time-point (Fig 3J). This confirms liver damage as shown from histology of NR mice. 465 
 466 
Lipid metabolism in R mice and NR mice 467 
At the age of 6-7 weeks old, at TNO mice were tested for total cholesterol and triglycerides 468 
plasma levels to discriminate between R mice and NR mice. As expected, R mice displayed 469 
higher plasma cholesterol (2.9  0.1 mmol/L; i.e.113.2  3.8 mg/dL) compared to NR mice 470 
(1.7  0.0 mmol/L; i.e. 68.4  1.9 mg/dL) (Fig 6A). Plasma total cholesterol was measured 471 
again upon arrival at our facility on chow diet, and after 1, 2 and 3 months of HFHC diet. 472 
Particularly during the first 2 months on HFHC diet, R mice had significantly increased 473 
plasma total cholesterol whereas cholesterol levels in NR mice remained similar to the 474 
chow-feeding period (Fig 6B). However, after 3 months of HFHC diet, NR mice showed 475 
significantly higher values (81.6  3.8 mg/dL) in total cholesterol compared to chow (34.4  476 
2.9 mg/dL) (Fig 6B).  477 
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Triglycerides plasma levels were higher in R mice (3.9  0.2 mmol/L; i.e. 341.5  13.7 478 
mg/dL) vs NR mice (0.9  0.0 mmol/L; i.e. 79.4  2.4 mg/mL) at the age of 6-7 weeks old, 479 
when measured at TNO (Fig 6C). Similar to total cholesterol, HFHC diet feeding resulted in 480 
significantly higher triglycerides concentrations in R mice than in NR mice (Fig 6D). R mice 481 
fed the HFHC diet showed uniformly high HDL-cholesterol (HDL-C) level, regardless of the 482 
duration of HFHC feeding (Fig 6F). 483 
Free fatty acids (P<0.05, Fig 6G) were also significantly increased after 3 months of HFHC 484 
diet. No difference was noticed in beta-hydroxybutyrate levels between NR mice and R mice 485 
(Fig 6H).   486 
At time of sacrifice, CETP activity, the enzyme that facilitates the transport of cholesterol 487 
ester and triglycerides between lipoproteins, was slightly higher in NR mice compared to R 488 
mice (4704  324 pmol transferred vs 3488  537 pmol transferred), but the difference was 489 
not significant (Fig 6E). 490 
Together, these results demonstrate that the lipid profile in R mice is markedly altered 491 
compared to NR mice kept under a HFHC diet feeding regimen. 492 
 493 
Bile acid profile in plasma and feces 494 
Plasma levels of bile acids were investigated at time of sacrifice (Fig 7A-L). Overall, R mice 495 
showed decreased total bile concentrations; particularly, among free bile acids, cholic acid 496 
(CA), deoxycholic acid (DCA), and -muricholic acid (-MCA) compared to NR mice (Fig 7A-497 
H). All taurine-conjugated bile acids were also lower in NR mice compared to R mice (Fig 7I-498 
L). Fecal coprostanol excretion was higher in R mice compared to NR mice (Fig 7M). No 499 
other differences were found in excreted bile acids between R mice and NR mice (Fig 7M-500 
V).  501 
  502 
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Discussion  503 
This study aimed to characterize the long-term effect of a 60% kcal fat diet supplemented 504 
with 0.25% cholesterol (HFHC) diet on various parameters linked to glucose and lipid 505 
metabolism in ApoE3L.CETP mice, a humanized mouse model for the MetS (51). The 506 
mutation ApoE3Leiden (14, 60) and the human transgene CETP gene (60) enable these 507 
mice' lipid metabolism and profile to be more similar to humans, hence they are one of the 508 
suitable animal models available to assess alterations in lipid metabolism in response to 509 
HFHC diet (51, 60). 510 
 511 
ApoE3L.CETP mice exhibit a dyslipidemic phenotype combined with obesity, insulin 512 
resistance and atherosclerosis when administered HFHC diet (7, 20, 23, 54). Interestingly, 513 
some degree of phenotypic heterogeneity has been reported among age-matched 514 
individuals kept under similar experimental conditions (37). Mice that do not fully display the 515 
expected phenotype, i.e., increased body weight and increased triglycerides and total 516 
cholesterol levels after HFHC diet exposure, are classified as non-responders (NR) and 517 
represent approximately 20% of the total ApoE3L.CETP mice population at TNO (TNO 518 
innovation for life, Leiden, The Netherlands; personal communication), the facility that 519 
established this mouse model and supplied them for this current study. In fact, NR mice and 520 
R mice can already be differentiated at young age when chow fed, based on their prevailing 521 
triglyceride and cholesterol plasma levels. To our knowledge, the reasons for these 522 
phenotypic differences between R mice and NR mice have never been addressed in detail 523 
and it is not clear why ApoE3L.CETP mice sharing the same genetic background exhibit 524 
heterogeneous responses to HFHC diet. In addition, in some previous published studies, it is 525 
not explicitly mentioned whether NR mice were included (11, 37, 51). This warrants overall 526 
caution when evaluating heterogeneous metabolic profiles and responses in ApoE3L.CETP 527 
mice that might be related to the dimorphic phenotype of R mice and NR mice (37).  528 
To assess the heterogeneity of the ApoE3L.CETP mice responses and to test the suitability 529 
of these mice to study the MetS (37), we investigated in detail body weight gain, feeding 530 
Downloaded from www.physiology.org/journal/ajpgi by ${individualUser.givenNames} ${individualUser.surname} (130.060.098.172) on August 9, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
 22 
behavior, glucose metabolism, lipid profile, liver histology and inflammation markers over 531 
time in several cohorts of mice, and compared mice that were classified as young animals 532 
as R mice to mice that were classified as NR mice. In line with what has been previously 533 
observed (37), our results confirmed a sharp distinction between R mice and NR mice 534 
responses to a HFHC diet. Mice originally classified as R mice were more prone to display 535 
the features of the MetS, and exhibited increased body weight, increased subcutaneous and 536 
intra-abdominal adipose tissues, increased plasma total cholesterol, triglycerides and HDL-C 537 
(11, 37, 51, 60), and reduced glucose sensitivity (31, 63) compared to NR mice. In line with 538 
lipid metabolism parameters, histological analysis showed that hepatocellular lipidosis in R 539 
mice administered HFHC diet for 2, 3 or 4 months occurred with a high severity progressing 540 
over time (average severity: 3.3 ± 0.2, corresponding to 76.6% lipid content in the ORO 541 
stained liver sections), whilst NR mice exhibited reduced levels of hepatic lipidosis (average 542 
severity: 1.8 ± 0.2, corresponding to 53.1% lipid content in the ORO stained liver sections). 543 
Surprisingly, however, NR mice showed prominent hepatic inflammatory and proliferative 544 
changes, characterized by severe diffuse chronic lymphohistiocytic infiltration, bile duct 545 
proliferation, and, rarely, foci of hepatocellular alteration, and hepatic adenomas. R mice, in 546 
contrast, exhibited only minimal inflammation and bile duct proliferation, in the absence of 547 
preneoplastic or neoplastic lesions. On an individual basis, there was a clear inverse 548 
correlation between the severity of chronic inflammation, and hepatocellular lipidosis, with 549 
mice that had high inflammatory scores showing low accumulation of hepatic lipids and 550 
decreased body weights, and vice-versa. This indicates that the hepatic pathology seen in 551 
NR mice may have a detrimental effect on hepatic function, as indicated by decreased lipid 552 
accumulation which we interpret as an inability to metabolize fat properly and increased 553 
levels of ALT. 554 
Differences in liver histology between R mice and NR mice were prominent following 2-4 555 
months of HFHC diet feeding, however minimal inflammatory changes were already 556 
observed in NR mice at an earlier age (12-16 weeks) while kept on chow diet. Age-matched 557 
R mice kept under the same experimental conditions had no histological abnormality in the 558 
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liver. This suggest that the peculiar NR liver phenotype is likely independent from HFHC, 559 
although further studies are needed to confirm this and assess the progression on the 560 
disease in NR mice fed a normal chow diet. 561 
 562 
High body weight, high cholesterol and triglycerides levels and a liver histology dominated 563 
by lipidosis and minimal inflammatory changes are therefore the salient features of a 564 
responsive R phenotype. From our data, it seems that separation between R mice and NR 565 
mice conducted at an early stage based on triglycerides levels (<2mmol/L, i.e., 177 mg/mL) 566 
seems to be generally predictive of the final phenotype. However, we noted a certain degree 567 
of heterogeneity also within R and NR mice groups, leading to a partial overlap between the 568 
two groups. There were indeed a few mice within each cohort that did not show the 569 
predicted phenotype. For instance, 2/32 in the R mice (6.2%) group might be considered as 570 
outliers, i.e. mice originally classified as responders which exhibited low body weight (28.3 g 571 
and 35 g), low hepatic lipidosis histological scores (mainly macrolipidosis scored 2 or 3) and 572 
high levels of chronic inflammation (scored as 4). In the NR cohort, 3/30 mice (10%) 573 
exhibited parameters consistent with a responder mouse, with higher body weight gain (40, 574 
49 and 51 g), high lipidosis levels (mainly microlipidosis: scored as 4) and low levels of 575 
chronic inflammation (scored 0 or 1).  576 
We suggest, therefore, that the introduction of other parameters such as liver histology might 577 
be helpful for the final classification of mice. It is important to note that a heterogeneity in the 578 
response to HFHC diet is also observed in humans with dysregulated metabolism, and it had 579 
to be taken in to account when transferring knowledge from an animal model to humans (28, 580 
51).  581 
In our study, we maintained the arbitrary classification carried out based only on cholesterol 582 
and triglycerides, given that the pathophysiological mechanisms underlying the NR 583 
phenotype are unknown and might have a multifactorial origin. Lack of the expected 584 
response might be related to the C57BL/6J strain background, as it has been previously 585 
shown by Burcelin et al (5) and Hull et al (18). In these studies, it was reported that 586 
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C57BL/6J mice do not respond uniformly to HFHC diet feeding. Indeed, some mice gained 587 
weight, developed obesity and glucose intolerance, while some others did not (31, 49, 52, 588 
61, 63). The reason for this different response has not been clarified to date.  589 
 590 
We originally hypothesized that the difference between R mice and NR mice might be due to 591 
different copy numbers of the CETP transgene or to altered transgene expression. While we 592 
did not directly measure copy numbers of the CETP transgene in NR mice and R mice, this 593 
seems to be unlikely based on our results, as the measured CETP activity did not differ 594 
between NR mice and R mice. 595 
It has been previously reported that APOE3Leiden gene overexpressing strains exhibit 596 
typical round cytoplasmic eosinophilic droplets, predominantly in the periportal hepatocytes 597 
(30). These characteristic inclusions are consistent with aggregates of ApoE3Leiden, 598 
however the mechanisms which lead to their accumulation are still poorly understood.  We 599 
noted that NR mice fed with a chow diet had higher numbers of cytoplasmic inclusions 600 
compared to R mice. This difference appeared more evident following HFHC diet feeding. A 601 
possible explanation might be that excessive accumulation of ApoE3Leiden protein elicits 602 
some form of damage, followed by an inflammatory response; however considerably more 603 
work will need to be done to elucidate a possible link between the presence of ApoE3Leiden 604 
and a NR phenotype. 605 
 606 
Chronic-active inflammation, associated with cholangitis, biliary hyperplasia and proliferative 607 
hepatocellular lesions has been described in the liver of mice following chronic infection by 608 
Helicobacter hepaticus (17, 50). Whilst most animals that carry Helicobacter spp. are 609 
asymptomatic, susceptible strains and individual mice might manifest clinical signs and 610 
lesions and we questioned whether the NR mouse phenotype could be simply the 611 
expression of an environmental infection in a proportion of more susceptible mice. FELASA-612 
accredited health check analyses that were conducted at the originating facility, as well as at 613 
our premises, revealed that the cohorts of mice employed in the current study did not carry 614 
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pathogenic etiologic agents. There was no evidence of bacterial organisms in the livers of 615 
selected NR mice subjected to a silver stain for the detection of argyrophilic bacteria such as 616 
Helicobacter spp.  Absence of Helicobacter was further confirmed by a qPCR analysis 617 
conducted on a pooled liver specimen obtained from R mice and NR mice.  618 
 619 
Since R mice and NR mice did not show any differences in daily food intake or in their 620 
feeding behavior, the fact that NR mice did not increase their body weight as much as R 621 
mice cannot be explained by a diet-related aspect or a decrease in food intake. Interestingly, 622 
energy expenditure also did not differ between R and NR mice but we did not quantify total 623 
caloric loss via the feces as a possible mechanism. 624 
 625 
Moreover, glucose metabolism was different between R mice and NR mice, and the 626 
difference was more prominent on HFHC diet feeding condition. Particularly, when HFHC 627 
diet fed, R mice showed increased basal blood glucose compared to NR mice suggesting 628 
that HFHC diet alters the basal glucose metabolism in R mice, and to a lesser extent in NR 629 
mice; this is in line with previously published studies (27). We noticed a tendency toward 630 
glucose intolerance in R mice similarly to what reported in previous studies conducted with 631 
C57BL/6J that also show an increase in basal blood glucose values after HFHC diet (1, 31, 632 
49, 52, 62). Even though NR mice showed better glucose tolerance and insulin sensitivity 633 
during OGTT and IST, their basal values also slightly increased over time as a potential 634 
consequence of HFHC diet and aging (21).  635 
We did not find histological abnormalities in the pancreas of R and NR mice that might 636 
explain the difference in glucose tolerance. Moreover, insulin secretion after glucose 637 
stimulation in islets isolated from R mice and NR mice did not show any differences. This 638 
indicates that insulin sensitivity rather than insulin secretion may be more critical for the 639 
different glucose tolerance observed in R mice compared to NR mice. We did not perform a 640 
hyperinsulinemic euglycemic clamp to investigate the animals' insulin sensitivity in detail. 641 
 642 
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Studies in humans (41) and animal models showed the increasing importance of bile acids 643 
in modulating body glucose, lipid metabolism and body weight (29). Our findings are 644 
contrary from previous data employing the same mouse model (37): surprisingly our results 645 
show decreased levels of most of the circulating bile acids (CA, DCA, TDCA, TCDCA, 646 
TUDCA, TA/TB-MCA) in R mice compared to NR mice. We hypothesized that these 647 
differences in bile acids between R mice and NR mice are due to a dysregulation of bile 648 
acids metabolism: in fact, because of the severe liver pathology affecting NR mice, NR mice 649 
might be unable to reabsorb and recycle bile acids via hepatic portal vein circulation, hence 650 
bile acids might tend to accumulate in the systemic circulation, potentially explaining higher 651 
bile acids values in NR mice compared to R mice (6).  652 
Indeed, some studies using another mouse model had shown how increased levels of MCA, 653 
as seen in our NR mice, might protect against body weight gain, steatosis, 654 
hypercholesterolemia and insulin resistance (4). Higher CA levels in NR coupled with lower 655 
hepatic TG levels confirmed also previous data (59). Furthermore, different metabolism of 656 
bile acids by gut microbiota may also explain why R mice and NR mice might show 657 
differences in their bile acids profile (46) but this was not formally tested in our studies. 658 
 659 
Another aspect to take into consideration is that obesity is often accompanied by an 660 
increase in the inflammatory status in mice (52) and humans (16, 32, 42). Our data indicate 661 
that circulating cytokines did not differ between R mice and NR mice; hence, the 662 
inflammation observed in livers of NR mice appears to be organ specific rather than a 663 
systemic feature of NR mice compared to R mice (52). 664 
 665 
In summary, our findings suggest that in the context of the heterogeneity previously 666 
described for the ApoE3L.CETP mice, two different and distinct phenotypes need to be 667 
considered: R mice and NR mice. Particularly, R mice showed the expected phenotype after 668 
HFHC diet feeding, confirming its use as a suitable mouse model to describe the MetS 669 
especially in relation to lipid metabolism.  670 
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With respect to the histological liver finding, these recapitulate partly those seen in NAFLD 671 
and likely shares similar pathophysiological mechanisms. As shown by Lau et al (26) several 672 
mice models were used to investigate NAFLD as C57BL/6, db/db and ob/ob mice. 673 
Nevertheless, we would rather consider the use of C57BL/6 mice as more accurate model 674 
for NAFLD (8, 45), since ApoE3L.CETP mice showed other liver histological features (i.e. 675 
minimal bile duct proliferation) that can create confounding factors.  676 
The fact that NR mice do not "respond" to the HFHC diet may therefore indicate that these 677 
animals may be protected from the development of diet-induced obesity (and its 678 
consequences) in the classical sense, but that the NR mice may in fact be unable to respond 679 
adequately to the HFHC diet because of compromised liver function. For this reason, the 680 
liver pathology in NR mice would rather not be classified as nonalcoholic steatohepatitis 681 
(NASH), i.e.  a more aggressive phenotype of NAFLD (36).   682 
We therefore suggest using NR mice with caution; it may be safer to use only R mice in 683 
experimental settings and to compare them to appropriate controls within the R cohorts, 684 
rather than taking NR mice as control groups. Indeed, we would suggest the use of R mice 685 
that are chow fed, huCETP mice or ApoE-/- mice that are fed either chow or the HFHC diet. 686 
It may also be advised to reclassify the mice based on the post mortem examination and 687 
clinical chemistry analysis, to confirm their R mice phenotype based on liver histology and 688 
function, respectively.  689 
 690 
Limitations and further directions 691 
The current study characterizes in detail the presence of two different phenotypes in 692 
ApoE3L.CETP mice, which could explain the heterogeneous metabolic profiles reported 693 
previously in this syngenic mouse model. In particular, we provided a detailed analysis of the 694 
morphological, metabolic and functional aspects inherent to these two phenotypes and have 695 
tried to rule out genetic background influences and environmental factors as a possible 696 
reason for the severe inflammatory and proliferative disease observed in the liver of NR 697 
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mice. The latter analysis however was limited to an initial investigation and requires further 698 
studies to fully understand the pathogenesis leading to the NR mice hepatic phenotype.  699 
In primis, the analysis should be extended also to females and include older animals, to 700 
assess its progression over time, and over gender. Particularly we investigated only male 701 
because compared to female ApoE3L.CETP they better show the MetS phenotype while 702 
females are more suitable for atherosclerosis studies (25, 53). We are aware of the 703 
importance of gut microbiota in the scientific community nowadays and further studies with a 704 
proper investigation of the gut microbiome of these mice might help in understanding the 705 
differences in phenotype between R mice and NR mice.  706 
To better understand the importance of R mice in describing the MetS, we would suggest 707 
not only to have other controls as R mice chow fed, huCETP mice, and, also ApoE-/- mice 708 
chow fed and HFHC diet. Particularly, only considering proper R mice we would investigate 709 
more in details liver function to better explain the mechanisms underneath the MetS.  710 
  711 
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Table 1: Experimental design 722 
 723 
 724 
 725 
 726 
Mice	experimental	design	
TNO	facility	
weeks -1 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
mice	age	 6-7	wks	 7-19	wks
group	1						 TC/TG OGTT OGTT OGTT OGTT sacrifice/islets
IST IST IST IST
blood	 blood	 blood	 blood	
8-14	wks	
group	1						 TC/TG OGTT OGTT OGTT OGTT
IST IST IST IST
blood	 blood	 blood	 blood	
group	3	 TC/TG sacrifice/histology
TC:	total	cholesterol	
TG:	triglycerides
NEFA:	non-esterified	fatty	acids
BHB:	betahydroxybutyrate	
OGTT:	oral	glucose	tolerance	test
IST:	insulin	sensitivity	test
HDL-C:	high.density	lipoprotein
ALT:	alanine	aminotransferase
blood:	 TC,	TG,	HDL-C	time-point	measurements
sacrifice terminal	blood	collection,	NEFA,	BHB,	cytokines,	ALT	
Indirect	calorimetry
sacrifice/islets
sacrifice/islets
2nd	cohort	
mice
adaptation	
chow	diet	 high	fat	high	cholesterol	diet	
1st	cohort	
mice
TC/TG
Zürich	facility	
group	2							
group	2							 TC/TG sacrifice/islets
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Table 2: Incidence and severity of histological findings in the liver of R and NR mice 727 
administered a chow and HFHC diet  728 
 Chow diet HFHC diet 
  R NR R NR 
Age mice (weeks) 12-16 12-16 28-34 28-34 
Livera 5 5 32 30 
Hepatocellular Lipidosisb 0/5 0/5 32/32 30/30 
Grade 0 5 5 0 0 
Grade 1 0 0 4 9 
Grade 2 0 0 1 15 
Grade 3 0 0 8 5 
Grade 4 0 0 19 1 
Average severityc 0  0 0  0 3.3  0.2 1.7  0.2*** 
Chronic Inflammationb 0/5 5/5 14/32 28/30 
Grade 0 5 0 18 2 
Grade 1 0 5 13 0 
Grade 2 0 0 1 3 
Grade 3 0 0 0 12 
Grade 4 0 0 0 13 
Average severityc 0  0 1 0 0.5  0.1 3.2  0.4*** 
Hepatocellular Eosinophilic Cytoplasmic 
Inclusionsb 
5/5 5/5 19/32 28/30 
Grade 0 0 0 13 2 
Grade 1 0 0 12 5 
Grade 2 1 0 7 14 
Grade 3 3 0 0 9 
Grade 4 1 5 0 0 
Average severityc 3  0.3 4  0 0.8  0.2 2.0  0.3 
Focus of the hepatocellular alterationb 0/5 0/5 0/32 1/30 
Hepatocellular adenomasb 0/5 0/5 0/32 2/30 
 729 
a: number of liver samples analysed, b: incidence of the findings, c:The average severity of 730 
each finding was calculated by summing the severity grades and dividing the total by the 731 
number of animals within each group 732 
 733 
***: p<0.001, NR v R, resp., unpaired Student’s T test   734 
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Table 3: Incidence and severity of histological findings in the liver of R and NR mice 735 
administered a chow and HFHC diet at different time-points 736 
 Chow diet HFHC – 8 weeks HFHC – 12 weeks HFHC – 16 weeks 
 R NR R NR R NR R NR 
Age mice 
(wks) 
12-16 12-16 20-26 20-26 24-30 24-30 28-34 28-34 
Liver a 5 5 8 8 11 13 13 9 
Hepatocellular 
lipidosisb 
0/5 0/5 8/8 8/8 11/11 13/13 13/13 9/9 
Grade 0 5 5 0 0 0 0 0 0 
Grade 1 0 0 2 4 1 2 1 3 
Grade 2 0 0 0 3 1 7 0 5 
Grade 3 0 0 2 0 5 4 1 1 
Grade 4 0 0 4 1 4 0 11 0 
Average 
severityc 
00 00 3.10.3 1.70.4 30.3 2.10.2 3.70.2 1.80.2*** 
Chronic 
inflammationb 
0/5 5/5 4/8 6/8 3/11 13/13 3/13 8/9 
Grade 0 5 0 4 2 8 0 10 1 
Grade 1 0 5 2 0 3 0 3 0 
Grade 2 0 0 1 0 0 2 0 0 
Grade 3 0 0 0 1 0 3 0 0 
Grade 4   1 5 0 8 0 8 
Average 
severity 
00 10 10.5 2.80.6* 0.30.1 3.50.2*** 0.20.1 3.50.4*** 
Hepatocellular 
eosinophilic 
cytoplasmic 
inclusionsb 
5/5 5/5 5/8 7/8 6/11 13/13 8/13 8/13 
Grade 0 0 0 3 1 5 0 5 1 
Grade 1 0 0 1 1 5 3 6 1 
Grade 2 1 0 4 2 1 7 2 5 
Grade 3 3 0 0 4 0 3 0 2 
Grade 4 1 5 0 0 0 0 0 0 
Average 
severity 
30.3 40 1.10.3 2.10.4 0.60.2 20.2*** 0.80.2 1.90.3** 
Focus of the 
hepatocellular 
alterationb 
0/5 0/5 1/8 2/8 1/11 3/13 1/13 4/9 
Hepatocellular 
adenomasb  
0/5 0/5 0/8 0/8 0/11 1/13 0/13 2/9 
 737 
a: number of liver samples analysed, b: incidence of the findings, c: The average severity of 738 
each finding was calculated by summing the severity grades and dividing the total by the 739 
number of animals within each group 740 
 741 
 742 
*, **, ***: p< 0.05, 0.01, or 0.001 NR vs R. resp., unpaired Student’s T-test  743 
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Figures legend 744 
Fig 1: (A) Body weight over a 16-weeks period on HFHC diet in responders (R mice, n=51) 745 
and non-responders (NR mice, n=52) ApoE3L.CETP male mice; R mice increased body 746 
weight more compared to NR mice with HFHC diet feeding. (B) average 24h food intake and 747 
(C) average number of meal bouts in 24h after 8 weeks on HFHC diet in R mice (n=8) and 748 
NR mice (n=8); mice displayed no differences between the two groups. (D) Respiratory 749 
Exchange Ratio and (E) Energy Expenditure in R mice (n=8) and NR mice (n= 8) mice after 750 
10 weeks on HFHC diet; no significant differences were found. (F) Lean and fat mass did not 751 
differ between R mice (n=7) and NR mice (n=7). (G) Subcutaneous and intra-abdominal fat 752 
mass revealed increased intra-abdominal fat mass in R mice. Data are represented as mean 753 
± SEM. *, *** P< 0.05 or 0.001, resp., NR vs. R, after post hoc Sidak adjustment significant 754 
intergroup differences were found by 2-way ANOVA multiple comparison (A, D, E) or 755 
unpaired Student’s T test, (B, C, F, G).  756 
 757 
Fig 2: Oral glucose tolerance test was performed in responder mice (R mice = 28) and non-758 
responders (NR mice =28) mice on chow (A), and after 1 (B), 2 (C) and 3 (D) months of 759 
HFHC diet. R mice from 1 month of HFHC diet displayed glucose intolerance compared to 760 
NR mice. (I) Area under the curve (AUC) over 120 min was calculated during the OGTT, 761 
above the lowest glucose value of each respective animal.  762 
Insulin sensitivity test was performed in responder mice (R mice = 19) and non-responder 763 
mice (NR mice = 15) on chow (E), and after 1 (F), 2 (G) and 3 (H) months of HFHC diet. At 764 
each time-point R mice displayed lower insulin sensitivity compared to NR mice. (J) Area 765 
under the curve (AUC) over 120 min was calculated during IST above the lowest glucose 766 
value during the test.  767 
Data represented as mean ± SEM., *, **, *** P < 0.05, 0.01, or 0.001 NR vs. R, resp., after 768 
unpaired Student’s T test (A-D) or after post hoc Sidak adjustment significant intergroup 769 
differences were found by 2-way ANOVA multiple comparison (I, J) (E); different letters 770 
indicate significant differences. 771 
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Fig 3: (A - B) microphotographs of livers from R mouse (A) and NR mouse (B) after 3 772 
months-HFHC diet. (A) R mouse liver show diffuse light brown discoloration, seems to 773 
correlate histologically with mild lipidosis. (B) NR mouse liver show multifocal well 774 
demarcated nodular masses (arrows; hepatocellular adenoma). (C and D) HE-stained liver 775 
sections from NR and R mice on a chow diet, scale bars = 100 µm: (C) Presence of 776 
eosinophilic cytoplasmic droplets (arrowheads), within the hepatocytes of a R mouse, (D) 777 
Minimal chronic inflammation (arrow) in a NR mouse liver. (E-F) HE-stained liver sections 778 
from mice on a HFHC diet, scale bars = 500 µm. Insets: Oil red O (ORO) stained liver 779 
sections from the same mice, scale bars = 20 µm: (E) High grade, predominantly 780 
microvesicular lipidosis (*) in a R mouse liver. Inset: a high proportion of the hepatocytes 781 
contains large cytoplasmic ORO-positive lipid droplets.  (F) mild, predominantly 782 
macrovesicular lipidosis (*) is observed in the liver of a NR mouse. Inset: ORO-positive lipid 783 
content within the hepatocytes is decreased compared to E. (G) triglycerides levels 784 
measured in the livers of NR mice (n=10) and R mice (n=10) after sacrifice and (H) non-785 
esterified fatty acids assessed in livers of NR mice (n=17) and R mice (n=15). (I) Absolute 786 
liver weight in R and NR mice on 2, 3 and 4 months of HFHC diet. (J) Alanine transaminase 787 
(ALT) plasma levels in R mice (n=7) and NR mice (n=9) chow fed and after 43 months of 788 
HFHC diet.  Data are represented as mean ± SEM. *, *** P<0.05 or 0.001, NR vs. R, resp., 789 
after unpaired Student’s T test (G-H) or after post hoc Sidak adjustment significant 790 
intergroup differences were found by 2-way ANOVA multiple comparison (I and J); different 791 
letters indicate significant differences.  792 
 793 
Fig 4: (A - B) HE-stained liver sections from mice fed HFHC diet, scale bars = 100 µm. (A) A 794 
R mouse liver with minimal chronic inflammation, characterized by scattered inflammatory 795 
cells (open arrowhead) and negligible bile duct proliferation (arrow). Moderate numbers of 796 
eosinophilic cytoplasmic droplets (black arrowhead) are detected. (B) A NR mouse liver with 797 
a marked chronic inflammatory reaction, represented by mononuclear cell infiltration (black 798 
arrowhead) and prominent bile duct proliferation (open arrowhead). (C-J) Liver sections from 799 
Downloaded from www.physiology.org/journal/ajpgi by ${individualUser.givenNames} ${individualUser.surname} (130.060.098.172) on August 9, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
 35 
a R mouse (C-F) and a NR mouse (55) on a HFHC diet, subjected to immunohistochemistry 800 
against the CD3 (T lymphocytes, C/G), CD45R/B220 (B lymphocytes, D-H), F4/80 801 
(macrophages, E-I) and cytokeratin (biliary ductal epithelial cells, F-J) antigens, scale bars = 802 
50 µm. Arrowheads positive reaction. (K-L) Liver sections from a R mouse (K) and a NR 803 
mouse (L) on a HFHC diet, subjected to immunohistochemistry against the CD45. CD45-804 
positive cells (black arrowheads) are more numerous in NR mouse liver.  805 
Microphotographs are taken from the same area depicted in A or B, respectively, (M-N) HE-806 
stained liver sections from NR mice on a high fat high cholesterol (HFHC) diet. (M) Focus of 807 
cellular alteration (arrowheads), scale bar = 500 µm. Insets: Higher magnification of the 808 
lesion, scale bar = 50 µm. (N) Hepatocellular adenoma (arrowheads), scale bar = 1 mm. (O-809 
V) HE-stained aorta and PBAT (O-S), kidney (P-T) epididymal WAT (Q-U), and heart (R-V) 810 
from R mouse (O-Q-S-U) and NR mouse (P-R-T-V) scale bars = 100 µm. No histological 811 
abnormality is recognized. (W-Y) Quantification of are of CD45-positive stained cells/mm2 in 812 
the liver (W) and kidneys (Y) of NR mice and R mice. Data are represented as mean ± SEM. 813 
*, P<0.05, NR vs. R, resp., after unpaired Student’s T test. 814 
 815 
Fig 5: Plasma cytokines in plasma from non-responder (NR mice, n=7) and responder (R 816 
mice, n=9) mice at the time of sacrifice: (A) Interferon- , IFN-. (B) Interleukin 10, IL-10. (C) 817 
Interleukin 12p70, IL-12p70. (D) Interleukin 1, IL-1. (E) Interleukin 2, IL-2. (F) Interleukin 4, 818 
IL-4. (G) Interleukin 5, IL-5. (H) Interleukin 6, IL-6. (I) Keratinocyte chemoattractant/growth-819 
regulated oncogene, KC-PRO and (J) tumour necrosis factor , TNF-. No difference 820 
between the two groups was found. Data are represented as mean ± SEM. *, P< 0.05, NR 821 
vs. R, resp after unpaired Student’s T test.   822 
 823 
Fig 6: Plasma lipid profile in non-responder (NR mice, n=11) and responder (R mice, n=13) 824 
mice at different time points (A-H). Total cholesterol (A, B) and triglycerides (C, D) at aged 6-825 
7 weeks, analysis performed from TNO when discrimination between R mice and NR mice 826 
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took place (A, C) and at time 0 (chow fed upon arrival in our facility), and after 1, 2 and 3 827 
months of HFHC diet (B, D). (E) CETP activity at time of sacrifice in NR mice (n=10) and R 828 
mice (n=8); no difference was found. (F) HDL cholesterol (HDL-C) on chow diet upon arrival, 829 
and after 1, 2 and 3 months of HFHC. (G) non-esterified fatty acids (NEFA) were higher in R 830 
mice vs NR mice, and (H) and beta-hydroxybutyrate (BHB) in NR mice (n=10) and R mice 831 
(n=10). (I) Insulin secretion expressed as a percentage of total insulin content after glucose 832 
stimulated insulin secretion test (GSIS) in islets isolated from NR mice and R mice and 833 
cultured for 4 days. Data are represented as mean ± SEM. *, *** P< 0.05 or 0.001, resp., NR 834 
vs. R, after post hoc Tukey adjustment significant intergroup differences were found by 2-835 
way ANOVA multiple comparison (B, D, F, I) or unpaired Student’s T test, (A, C, E, G, H). 836 
Different letters indicate significant differences 837 
 838 
Fig 7: Total plasma bile (A-L) and total coprostanol (M), cholesterol (N) and total bile acid 839 
(O-U) in NR mice and R mice feces at time of sacrifice. (A) Total bile acids, total BA (n=17, 840 
20). (B) cholic acid, CA (n=14, 15). (C) chenodeoxycholic acid, CDCA (n=14, 10). (D) 841 
deoxycholic acid, DCA (n=17, 15). (E) -muricholic acid,  -MCA (n=13, 6). (F) -muricholic 842 
acid, -MCA (n=15, 14). (G) tauro cholic acids, TCA levels (n=15, 15). (H) taurodeoxycholic 843 
acid, TDCA (n=17, 15). (I) taurocheno deoxycholic acid, TCDCA (n=16,10), (J) 844 
tauroursodeoxycholic acid, TUDCA (n=17, 20), (K) tauro-α-muricholic acid, Tα-MCA (n=16, 845 
14) and (L) tauro--muricholic acid, T-MCA (n=17, 12). (M) Coprostanol, Copr (n=5, 2). (N) 846 
cholesterol, Chol (n=6, 5). (O) total bile acids, total BA (n= 6, 5). (P) dihydrocholestero,l 847 
diHyChol (n=5, 5). (Q) cholic acid, CA (n=6, 5). (R) allo cholic acid, alloCA (n=6, 5). (S) 848 
deoxy cholic acid, DCA (n=6, 5). (T) -muricholic acid,  -MCA (n=6, 5). (U) -muricholic 849 
acid, -MCA (n= 6, 5). (V) -muricholic acid, -MCA (n= 6, 5). (J). Data are represented as 850 
mean ± SEM. *, **, *** P< 0.05, 0.01 or 0.001, resp., NR vs. R, using unpaired Student’s T 851 
test.   852 
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